TotalMarketCap

Astrazeneca

AZNNYSE United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$246.224 B

$158.78 -0.84%

Close of 9 Oct 2026

As of 9 Oct 2026, Astrazeneca (AZN) has a market capitalization of $246.2B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #4Merck & Co.MRK$351.3B
  2. #5NovartisNVS$273.1B
  3. #6AstrazenecaAZN$246.2B
  4. #7Abbott LaboratoriesABT$170.4B
  5. #8Novo Nordisk A SNVO$169.1B

What if Astrazeneca were worth as much as…

Open the what-if tool →

Gold $29.1T

$18,740.81

Per share 118× higher

Bitcoin $1.66T

$1,070.84

Per share 6.74× higher

Nvidia $5.55T

$3,581.91

Per share 22.6× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Astrazeneca are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.